DKK1 and cancer: Furthermore, prognostic analysis of DKK1 expression in clinical samples from multiple cancers including gastric, lung, pancreatic, and head-neck squamous cell cancer (head-neck SCC) consistently revealed that patients with higher DKK1 expression exhibited worse overall survival outcomes (Supplementary Fig. 4h).